- 2020
- Press releases - 23.03.2020
Exploring the Brain to Clarify the Link Between Sleep Disorders and Alzheimer’s Disease
Sleep disorders have a harmful impact on our brain and under certain conditions are thought to be linked to an increased risk of Alzheimer’s disease. A link which had until now been poorly understood by the scientific community. For the first time, a study based on multiple brain imaging techniques has revealed, among other forms of impairment, the appearance of amyloid plaques characteristic of Alzheimer’s disease in the brains of older adults with sleep apnea but no cognitive disorders.
- What's on? - 23.03.2020
“Fake news” and misinformation around the SARS-CoV2 coronavirus
[/credits] As with all highly mediatized topics, SARS-CoV-2 has its share of misinformation. Originating in the Chinese province of Hubei in 2019, the epidemic caused by this novel coronavirus, now referred to as SARS-CoV-2, and COVID-19 for the disease it causes in people, continues to stoke the fires of not just the traditional media, but […]
- Press releases - 22.03.2020
Launch of a European clinical trial against COVID-19
A European clinical trial to evaluate four experimental treatments for COVID-19 starts this weekend. Coordinated by Inserm as part of the Reacting consortium, this trial will include at least 800 French patients with severe forms of COVID-19.
- Press releases - 20.03.2020
A Mushroom to the Rescue of Patients with Rare Genetic Diseases
An ordinary edible mushroom could be a game-changer when it comes to the treatment of rare genetic diseases. These affect hundreds of millions of people worldwide who often find themselves powerless in the absence of effective therapy. A team of researchers has shown that an active ingredient contained in the Lepista inversa mushroom has repair properties, making it possible to correct certain genetic mutations, known as “nonsense” mutations.
- Press releases - 12.03.2020
COVID-19: Tackling the Epidemic in 20 Research Projects
At a time when the Sars-CoV-2 epidemic is continuing to spread, France’s Alliance for Life Sciences and Health (Aviesan) is mobilizing to accelerate research into the virus and COVID-19 disease through REACTing – a consortium coordinated by Inserm. The Scientific Advisory Board of REACTing has selected 20 scientific initiatives covering diverse fields, from mathematical modelling to disease prevention and treatment.
- Press releases - 10.03.2020
Cancer: the immune system attacks tumors remotely
Using in vivo imaging tools, scientists from the Institut Pasteur and Inserm described the spatiotemporal activity of tumor-infiltrating T lymphocytes, both locally and remotely.
- Press releases - 10.03.2020
Menstrual Toxic Shock Syndrome: Wearing a Tampon for More Than Six Hours Increases Risk
Each year, some twenty cases of Staphylococcal toxic shock syndrome linked to tampon use are reported in France. Characterized by various symptoms, such as high fever and skin rash, it can lead to multiple-organ failure and death in the most extreme cases.
- Press releases - 05.03.2020
When Stress Weakens the Immune Defenses
In previous years, various studies have established a link between psychological stress and reduced immune defenses, but the mechanisms involved remained poorly elucidated.
- Press releases - 04.03.2020
Buruli Ulcer: New Diagnostic Avenues for a Neglected Disease
It is world’s third most common tropical mycobacterial disease after tuberculosis and leprosy. Caused by Mycobacterium ulcerans, it leads to the destruction of skin tissue and the development of large ulcers which can affect entire limbs right down to the bone.
- Press releases - 03.03.2020
Influenza: combating bacterial superinfection with the help of the microbiota
Researchers have shown for the first time in mice that perturbation of the gut microbiota caused by the influenza virus favours secondary bacterial superinfection. These results open up new prospects for the prevention and treatment of bacterial pneumonia, a major cause of death in elderly or vulnerable people infected with the influenza virus.